William Carl Fairey's most recent trade in Mirum Pharmaceuticals Inc was a trade of 3,203 Common Stock done at an average price of $48.4 . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Sale of securities on an exchange or to another person at price $ 48.42 per share. | 11 Jun 2025 | 3,203 | 2,500 (0%) | 0% | 48.4 | 155,091 | Common Stock |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,268 | 6,268 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 5,703 | 0 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 5,703 | 5,703 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3,977 | 3,977 | - | - | Deferred Stock Units | |
| Rein Therapeutics Inc. | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Rein Therapeutics Inc. | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 2,725 | 2,725 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Restricted Stock Units | |
| KalVista Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | William Carl Fairey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (right to buy) |